Daniels全球醫(yī)療保健轉(zhuǎn)型_第1頁
Daniels全球醫(yī)療保健轉(zhuǎn)型_第2頁
Daniels全球醫(yī)療保健轉(zhuǎn)型_第3頁
Daniels全球醫(yī)療保健轉(zhuǎn)型_第4頁
Daniels全球醫(yī)療保健轉(zhuǎn)型_第5頁
已閱讀5頁,還剩75頁未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

GlobalHealthcareTransformationBetterhealththroughInformationTechnologyrGlobalHealth?Doingmorewithless?Reducinghospital?Reducinghospitalmortality?Reducinghospitalacquired?Reducing‘never’events?ReducingLOS?Growingagingpopulation?ImprovingpatientsafetyImprovingefficiencyandImprovingstaffsatisfactionn?Reducinginequality?Justifyingtheinvestmentin?Protectingthosemostatrisk?Andmanyothers……Whatisdrivingthevision??In1999,IOMreportedmorethan98,000Americansdieinhospitalseachyearasaresultofmedicalerrors?7,000areestimatedtodiefrommedicationerrorsalone?57,000dieeachyearwithoutappropriatehealthcare?InEurope,missedhealthcareopportunitiescostEuropeansociety€70billionThesechallengesaresharedWorldwideProblemhasworsened–2016Why?LackLackofRelevantInformationatthePointofCareHowcanwetransformhealthcareInvestmentininformationtechnologyisneededtohelpmakehealthcare…Crossingthequalitychasm:Anewhealthsystemforthe21stmyPressthcareInformationTechnologythcareInformationTechnologylthcareInformationTechnologyQuickCaseStudy–UnitedStatesGlobalHIMSSAnalyticsEMRAdoptionModelSMGlobalHIMSSAnalyticsEMRAdoptionModelSM2011Q22014Q3CompleteEMR,DataAnalytics2011Q22014Q3Physiciandocumentation(templates),fullCDSS,loopmedicationadministrationAprogressivelysophisticatedroadmapAprogressivelysophisticatedroadmap…thatenables0%CPOE,ClinicalDecisionSupport(clinicalprotocols)Clinicaldocumentation,CDSS(errorQuality,Safety,&6.3%OperationsEfficienciesCDR,ControlledMedicalVocabulary,6.3%OperationsEfficienciesAncillaries-Lab,Rad,Pharmacy-AllAllThreeAncillariesNot4%4%2009–AmericanRecoveryandReinvestmentActWhatisARRA?WhatisMeaningfulUse?unched?USD$250Minvestedto…?Build/strengthenITinfrastructure&exchangecapabilities?Improvecost,quality,andpopulationhealth?Develop/accelerateinnovativeapproachestoperformancemeasurement,technology,andcaredeliveryunched?Conclusions?EHRadoptionincreased?HIEparticipationincreased?However…?Needmoretimetodevelopanddemonstrate?Alignmentbetweenregionalandgovernmentinitiativesiscritical?Needmoreanalysestodetermineneedandreturnoninvestment?Privatesectorstillunabletoachieveinteroperability18.7%17.4%3.1%0.5%0.1%0.0%20.4%18.7%17.4%3.1%0.5%0.1%0.0%20.4%40.0%01234567EMRAMStage19.3%14.0%2.2%0.8%0.0%25.1%19.3%14.0%2.2%0.8%0.0%25.1%37.2%01234567EMRAMStage35.7%31.4%15.6%2.5%22.5%0.5%0.3%0.5%01234567EMRAMStage16.9%7.4%7.27.4%3.8%0.7%01234567EMRAMStagenCommunitieslaunched14.6%10.5%10.10.5%7.1%3.2%4.53.2%01234567EMRAMStage???tsstart44.9%112.4%9.0%5.2%13.2%8.4%5.7%01234567EMRAMStage???e38.3%44.3%14.2%14.0%8.4%8.2%10.7%01234567EMRAMStage???e30.3%222.0%5.8%2.9%3.3%12.5%7.6%15.5%01234567EMRAMStage???e32.7%117.9%3.8%2.0%5.1%14.0%3.6%21.0%01234567EMRAMStageCommunitiesevaluationrnmentpaymentscontinue35.9%27.1%27.1%16.4%10.1%4.2%2.1%1.7%2.6%01234567EMRAMStagelsarelsare 2011lsarelsare 2011|MUPaymentslsare2009|2005|EMRAMLaunchedlsare20142010|BeaconCommunitiesARRAPassedlsare|MU2AdoptionModelSMke“significant”nationalprogressStage3%%4.2%0.1%.5%%.1%ge.5%4.5%.1%e.1%e%Stage1.1%N=4,237N=5,073N=5,166N=5,281N=5,337N=5,458N=5,458N=5,449N=5,467N=5,460DatafromHIMSSAnalytics?Database?nalEMRAMScoreDistributionacifice.5%4.2%2%0.1%e.1%4.6%tage.1%ge6%geStage148.2%.1%.1%N=770N=142N=5,460N=641N=2,395DatafromHIMSSAnalytics?Database?Canada,China,Germany,SouthKorea,Spain,SaudiArabia,TheNetherlands,Turkey,USAArgentina,Australia,Belgium,Brazil,Canada,Chile,China,Denmark,Finland,France,India,Ireland,Italy,Malaysia,SaudiArabia,Singapore,Switzerland,Taiwan,Thailand,TheNetherlands,Turkey,UAE,UK,USAProfileofaStage&7Organization?Usedatatodriveimprovedoutcomesrelatedto…–Process,Financial,Clinical,Quality&Safety?Arepaperless,ornearpaperless(createnopaper)–AllclinicallyrelevantdataisintheEMR?Arefullycommittedtocontinuousprocessimprovementthroughcollaboration–StrongITleadershipandexecutivechampions–Clinician/end-userchampionslDecisionSupportandClosedLoopMedicationAdministrationareKeyElementsofPatientSafety18.0%16.0%14.0%12.0%10.0%8.0%6.0%4.0%2.0%0.0%eMARManualTimingrelatederrorscriptionerrorsinceceEffectofBarCodeTechnologyontheSafetyofMedicationAdministrationPoonKeohaneBatesLipsitzetalNewEnglandJournalofMedicineMay6,2010PtScanPtScan:96%PtScanPtScan:96%19107CMI-AdjustedPatientDays0Jan2011Jan2013Jun2013TopPerformingHospitalsbyNumberMetricsExcellingInbyEMRAMStage.7%30.1%16.3%6.5%eSourceSource:HIMSSAnalytics?Logicm40intint49.045.544.638.945.945.9Stage0Stage1Stage2Stage3Stage4Stage5Stage6Stage7Sourc

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論